[Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)].
D000328:Adult; D001259:Ataxia / Q000150:complications* / Q000188:drug therapy; D001369:Axons; D002220:Carbamazepine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000175:diagnosis; D009461:Neurologic Manifestations; D010292:Paresthesia / Q000150:complications; D012640:Seizures / Q000150:complications* / Q000188:drug therapy; D013064:Speech Disorders / Q000150:complications* / Q000188:drug therapy; D013997:Time Factors; D014276:Trigeminal Nerve; D014786:Vision Disorders / Q000150:complications
D002220:Carbamazepine
Paroxysmale Dysarthrie und Ataxie. Ein pathognomonisches Anfallssyndrom bei multipler Sklerose